Member Exclusive

Drugging homologous recombination: back to the future

In this editorial, published recently in Future Medicinal Chemistry, authors Hannah Sanford-Crane, Tanja Pejovic and Xiangshu Xiao discuss the potential of homologous recombination inhibitors as novel anticancer therapies.


Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.